Wilder Fulford has advised the Boards, management and owners of companies in diverse industries on M&A, corporate finance and other strategic transactions for over 25 years.  He founded the investment banking firm THE FULFORD GROUP to provide independent M&A and strategic and financial advice and execution of the highest quality to companies, entrepreneurs and investors in Life Sciences, Healthcare, and other industries.

Dr Fulford founded the London office of Torreya Partners, a specialist life sciences advisory firm, in 2011.  Prior to that he was Head of European Healthcare M&A at Deutsche Bank, Head of European Healthcare Investment Banking at Bank of America, and Head of European Healthcare and Basic Materials M&A at Merrill Lynch.  He began his career in New York, working for a number of years as a venture capitalist, and then as an M&A banker at James D. Wolfensohn Inc. and as a partner at Salomon Brothers.  In his career he has undertaken hundreds of advisory assignments, and advised on over 100 completed transactions.  In recent years, he has advised on numerous healthcare mergers & acquisitions as well as life science and medtech partnering an licensing deals.
Dr. Fulford earned a PhD in Molecular Genetics from The Rockefeller University in 1986, and is an author of twelve published papers and abstracts.​